Billable / Specific Code
ICD-10-CM H35.053 is the diagnosis code for Retinal neovascularization, unspecified, bilateral. This code falls under the section "Disorders of choroid and retina" within Chapter 7 — Diseases of the eye and adnexa (H00-H59). It is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. Medical coders and healthcare providers use this code to document and classify diagnoses in electronic health records, insurance claims, and clinical databases.
Always refer to the official ICD-10-CM Tabular List for complete coding guidelines. Ensure documentation supports the specificity of the code selected. When in doubt, consult a certified medical coder or the latest CMS guidelines.
Understanding where H35.053 sits in the ICD-10-CM classification helps ensure proper coding:
Yes, H35.053 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
H35.053 is the ICD-10-CM diagnosis code for "Retinal neovascularization, unspecified, bilateral". It is used by healthcare providers to classify and document this condition in medical records and insurance claims.
The parent code of H35.053 is H35.05 ("Retinal neovascularization, unspecified"). H35.053 provides a more specific classification within this category.
H35.053 is located in Section H30-H36 — "Disorders of choroid and retina" within Chapter 7 of the ICD-10-CM Tabular List.
Use H35.053 when the patients documented diagnosis matches "Retinal neovascularization, unspecified, bilateral" and the clinical documentation supports this level of specificity. Always verify with the latest ICD-10-CM guidelines and payer requirements.
The ICD-10-CM code for Retinal neovascularization, unspecified, bilateral is H35.053.
Yes, H35.053 can be used as a primary diagnosis code since it is billable and specific.
H35.053 is in Chapter 7 of the ICD-10-CM Tabular List.
Yes, H35.053 is a valid ICD-10-CM code for the 2026 fiscal year, subject to official CMS updates.